Deeper Knowledge, Faster

  • Find suppliers and generic API sources
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Harvard Business School
Fish and Richardson
Johnson and Johnson

Generated: June 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 016862

« Back to Dashboard
NDA 016862 describes DARVON-N, which is a drug marketed by Aaipharma Llc and Xanodyne Pharm and is included in four NDAs. It is available from one supplier. Additional details are available on the DARVON-N profile page.

The generic ingredient in DARVON-N is aspirin; propoxyphene napsylate. There are twenty-one drug master file entries for this compound. Additional details are available on the aspirin; propoxyphene napsylate profile page.

Summary for NDA: 016862

Therapeutic Class:Analgesics
Formulation / Manufacturing:see details

Pharmacology for NDA: 016862

Mechanism of ActionFull Opioid Agonists

Suppliers and Packaging for NDA: 016862

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
propoxyphene napsylate
TABLET;ORAL 016862 NDA Stat Rx USA 16590-874 16590-874-30 30 TABLET, FILM COATED in 1 BOTTLE (16590-874-30)
propoxyphene napsylate
TABLET;ORAL 016862 NDA Stat Rx USA 16590-874 16590-874-60 60 TABLET, FILM COATED in 1 BOTTLE (16590-874-60)

Summary for product number 002

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength100MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Argus Health
Cantor Fitzgerald
Johnson and Johnson
Harvard Business School
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus